前收市價 | 227.56 |
開市 | 228.31 |
買盤 | 224.19 x 1100 |
賣出價 | 233.96 x 800 |
今日波幅 | 227.02 - 234.66 |
52 週波幅 | 195.47 - 254.00 |
成交量 | |
平均成交量 | 510,317 |
市值 | 23.012B |
Beta 值 (5 年,每月) | 0.83 |
市盈率 (最近 12 個月) | 41.94 |
每股盈利 (最近 12 個月) | 5.55 |
業績公佈日 | 2024年8月06日 |
遠期股息及收益率 | 2.08 (0.91%) |
除息日 | 2024年6月12日 |
1 年預測目標價 | 243.49 |
STERIS' (STE) first-quarter fiscal 2025 results are likely to reflect the positives of the normalization of the Healthcare backlog, along with a core focus on pharma and MedTech.
STERIS' (STE) AST successfully offers an extensive range of sterilization modalities through a worldwide network of more than 50 contract sterilization and laboratory facilities.
STERIS' (STE) Healthcare business and strong rebound prospects of the AST segment appear encouraging. However, macroeconomic concerns remain a challenge.